Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPATCH11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNFRSF10B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREBRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAFF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF224 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TCEANC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on